There are currently 47 active clinical trials seeking participants for Migraine research studies. The states with the highest number of trials for Migraine participants are Florida, California, Texas and New York.
Aimovig Pregnancy Exposure Registry
NCT06150781
Recruiting
The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.
Gender:
Female
Ages:
Between 18 years and 99 years
Trial Updated:
11/21/2023
Locations: IQVIA Virtual Site, Durham, North Carolina
Conditions: Migraine
Register for Updates
RELAXaHEAD for Headache Patients (Phase III)
NCT06077838
Recruiting
This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.
Gender:
All
Ages:
Between 16 years and 80 years
Trial Updated:
11/06/2023
Locations: NYU Langone Health, New York, New York
Conditions: Migraine
Register for Updates
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
NCT05175521
Recruiting
The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/18/2023
Locations: HonorHealth Bob Bové Neuroscience Institute, Scottsdale, Arizona
Conditions: Migraine
Register for Updates
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
NCT06016465
Recruiting
For some patients who come to the emergency department for treatment of a migraine headache, peripheral headache nerve blocks (PHNB) have proven to be an efficient and effective treatment for headache relief. Previous studies have demonstrated that adding steroids as an adjunct treatment to standard migraine treatment can reduce recurrence of headaches in the subsequent few days.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
09/26/2023
Locations: University Medical Center of El Paso, El Paso, Texas
Conditions: Migraine
Register for Updates
Migraine in Adolescents
NCT05654012
Recruiting
Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a. To determine hormonal, psychophysical, and neural changes associated with migraine onset. Aim 2b. To identify the temporal relationships between hormonal, psychophysical, and neural changes preceding vs. following migraine onset. Aim 3. To identify psychophysical and neural factors predicting migraine prognosis in adolescents with migraine.
Gender:
All
Ages:
Between 10 years and 13 years
Trial Updated:
08/28/2023
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Migraine
Register for Updates
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
NCT05738213
Recruiting
The purpose of this research study is to investigate the relationships between sex hormone levels and experimental pain sensitivity and migraine severity will be examined.
Gender:
All
Ages:
Between 11 years and 15 years
Trial Updated:
08/28/2023
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Migraine
Register for Updates
EMG Biofeedback Treatment for Chronic Low Back Pain, Cancer Pain and Migraines
NCT04607460
Recruiting
The purpose of this pilot efficacy study is to examine the effects of EMG-biofeedback (EMG-BF) on pain-related outcomes in Chronic Low Back Pain (CLBP) patients, Recent mastectomy and lumpectomy patients, and patients with episodic migraine. EMG-BF facilitates neuromuscular retraining and muscle relaxation by using audio and visual stimuli using an EMG surface electrode-based biosensor and a software installed on a tablet or smart phone. For this pilot efficacy study, we will recruit 125 patie... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
08/11/2023
Locations: Brigham and Women's Hospital, Chestnut Hill, Massachusetts
Conditions: Chronic Low-back Pain, Mastectomy, Lumpectomy, Migraine
Register for Updates
AVPI Migraine Study
NCT05537818
Recruiting
The study is designed as a multicenter, double-blind, randomized, sham-controlled trial to assess the safety and effectiveness of the Nocira AVPI Device for the acute treatment of migraine. The study is conducted in two phases in two study groups: Phase I - initial screening of device operation in both active and sham modes in-clinic and as proctored by the investigator, and Phase II - for further evaluation when used in the home (non-clinical) environment.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
05/08/2023
Locations: ReGen Pain & Wellness, Scottsdale, Arizona +2 locations
Conditions: Migraine
Register for Updates
Effects of a Multispecies Probiotic on Migraine
NCT04696458
Recruiting
The prevalence of migraine is higher in female patients with various intestinal diseases. An explanation could be that migraine is caused by a leaky gut, defined by increased intestinal permeability that permits particles to pass through the gastrointestinal wall. Probiotics, may be able to improve intestinal barrier function. OBJECTIVE: To test whether probiotics, as adjucnt therapy, can reduce incidence and severity of migraine attacks by reducing intestinal permeability.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
11/21/2022
Locations: Scripps Center for Integrative Medicine, La Jolla, California
Conditions: Migraine, Irritable Bowel Syndrome, Headache, Migraine
Register for Updates
Determining the Utility of a Behavioral Intervention in Chronic Migraine
NCT05415020
Recruiting
This proposal will involve a pilot study to evaluate the feasibility, acceptability, and outcomes of a lifestyle behavior protocol in managing chronic migraine. Additionally, the proposal will investigate biomolecules that are uniquely involved in chronic migraine patients who respond to the protocol. Successful completion of this proposal will inform the design of a future full-scale behavioral clinical trial to control chronic migraine.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/20/2022
Locations: Stanford University, Stanford, California
Conditions: Migraine, Headache, Migraine Disorders, Chronic Migraine, Lifestyle Factors, Headache Disorders
Register for Updates
Vagus Nerve Stimulation and Stress Reduction Training for Migraine
NCT03592329
Recruiting
This study design has two components: 1) a cross-sectional assessment of brain activity and inflammation in migraine patients compared to healthy controls and 2) an assessment of 8 weeks of a combination therapy approach to treating migraine.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
04/06/2022
Locations: Anthinoula A. Martinos Center, Charlestown, Massachusetts
Conditions: Migraine
Register for Updates